Berkshire invests in UnitedHealth, trims Apple stake

Warren Buffett's Berkshire Hathaway made significant portfolio adjustments in Q2, initiating a new $1.57 billion position in UnitedHealth Group (UNH) by acquiring 5.04 million shares, while simultaneously trimming its largest holding, Apple (AAPL), by selling 20 million shares. Concurrently, Berkshire diversified its equity exposure by acquiring stakes in Allegion (ALLE), DR Horton (DHI), Lamar Advertising (LAMR), and Nucor (NUE), and notably increasing its Lennar (LEN) holding, signaling a strategic rebalancing across healthcare, industrial, and consumer-cyclical sectors.

Analysis

Berkshire Hathaway's Q2 filings reveal a strategic portfolio rebalancing, characterized by a significant new investment in the healthcare sector and a broadening of exposure to cyclical industries, funded in part by trimming its largest holding. The conglomerate initiated a substantial $1.57 billion position in UnitedHealth Group, acquiring 5.04 million shares in a move that appears contrarian, given the article's note that the insurer is a target of public criticism. Simultaneously, Berkshire reduced its Apple stake by 20 million shares, a modest trim that still leaves it with 280 million shares, suggesting profit-taking or risk management rather than a fundamental shift in conviction. The new capital was also deployed to establish positions in homebuilder D.R. Horton, security provider Allegion, outdoor advertiser Lamar Advertising, and steel producer Nucor, while the existing stake in homebuilder Lennar was significantly increased. This pattern of investment indicates a bullish outlook on the U.S. housing market and a broader diversification into industrial and materials sectors.

Key Decisions for Investors

• The new positions, particularly the increased exposure to homebuilders D.R. Horton and Lennar, provide a strong bullish signal for the U.S. housing sector, warranting a review of exposure to this industry.
• While the sale of 20 million Apple shares is notable, it represents a minor reduction in a massive holding and should be viewed as prudent portfolio management rather than a bearish signal on the stock's fundamentals.
• Berkshire's $1.57 billion investment in UnitedHealth, despite negative public sentiment, signals a potential deep-value opportunity, and investors should consider this contrarian viewpoint when assessing the healthcare sector.
• Investors should anticipate heightened trading volume and positive price momentum in the newly disclosed holdings (UNH, DHI, ALLE, LAMR, NUE, LEN) due to the 'Buffett effect' in the near term.